Population proteomics: addressing protein diversity in humans
- 1 June 2005
- journal article
- Published by Taylor & Francis in Expert Review of Proteomics
- Vol. 2 (3) , 315-324
- https://doi.org/10.1586/14789450.2.3.315
Abstract
In the past several years, proteomics and its subdiscipline clinical proteomics have been engaged in the discovery of the next generation protein of biomarkers. As the effort and the intensive debate it has sparked continue, it is becoming apparent that a paradigm shift is needed in proteomics in order to truly comprehend the complexity of the human proteome and assess its subtle variations among individuals. This review introduces the concept of population proteomics as a future direction in proteomics research. Population proteomics is the study of protein diversity in human populations. High-throughput, top-down mass spectrometric approaches are employed to investigate, define and understand protein diversity and modulations across and within populations. Population proteomics is a discovery-oriented endeavor with a goal of establishing the incidence of protein structural variations and quantitative regulation of these modifications. Assessing human protein variations among and within populations is viewed as a paramount undertaking that can facilitate clinical proteomics' effort in discovery and validation of protein features that can be used as markers for early diagnosis of disease, monitoring of disease progression and assessment of therapy. This review outlines the growing need for analyzing individuals' proteomes and describes the approaches that are likely to be applied in such a population proteomics endeavor.Keywords
This publication has 78 references indexed in Scilit:
- Finishing the euchromatic sequence of the human genomeNature, 2004
- A Dataset of Human Liver Proteins Identified by Protein Profiling Via Isotope-coded Affinity Tag (ICAT) and Tandem Mass SpectrometryMolecular & Cellular Proteomics, 2004
- Selected expression profiling of full-length proteins and their variants in human plasmaClinical Proteomics, 2004
- FTICR mass spectrometry for qualitative and quantitative bioanalysesCurrent Opinion in Biotechnology, 2004
- Functional protein microarrays: ripe for discoveryCurrent Opinion in Chemical Biology, 2004
- Identification and validation of a potential lung cancer serum biomarker detected by matrix‐assisted laser desorption/ionization‐time of flight spectra analysisProteomics, 2003
- The Vision for a New Diagnostic ParadigmClinical Chemistry, 2003
- Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteinsJournal of Lipid Research, 2003
- Tabulation of human transthyretin (TTR) variants, 2003Amyloid, 2003
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001